Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Capital Expenditures (2017 - 2024)

MedWellAI (MWAI) has disclosed Capital Expenditures for 8 consecutive years, with $2242.0 as the latest value for Q3 2024.

  • On a quarterly basis, Capital Expenditures changed N/A to $2242.0 in Q3 2024 year-over-year; TTM through Jun 2025 was $2242.0, a N/A change, with the full-year FY2025 number at $2242.0, changed N/A from a year prior.
  • Capital Expenditures was $2242.0 for Q3 2024 at MedWellAI, up from -$1740.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $594331.0 in Q1 2021 to a low of -$737211.0 in Q2 2021.
  • A 5-year average of $29052.3 and a median of $6782.0 in 2021 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: surged 10916.33% in 2021, then crashed 96.33% in 2022.
  • MedWellAI's Capital Expenditures stood at $171605.0 in 2020, then tumbled by 96.05% to $6782.0 in 2021, then soared by 563.52% to $45000.0 in 2022, then tumbled by 96.13% to $1740.0 in 2023, then rose by 28.85% to $2242.0 in 2024.
  • Per Business Quant, the three most recent readings for MWAI's Capital Expenditures are $2242.0 (Q3 2024), -$1740.0 (Q2 2024), and $1740.0 (Q4 2023).